Related Experiment Video
Updated: Apr 21, 2026

Minimal Invasive Surgical Procedure of Inducing Myocardial Infarction in Mice
Published on: May 4, 2015
Varying definitions for periprocedural myocardial infarction alter event rates and prognostic implications
Hanan Idris1, Sidney Lo1, Ibrahim M Shugman1
1Cardiology Department, Liverpool Hospital and South Western Sydney Clinical School, The University of New South Wales, Sydney, NSW, Australia (H.I., S.L., I.M.S., Y.S., A.P.H., C.M., D.L., L.T., C.P.J., J.K.F.).
Background:
Periprocedural myocardial infarction (PMI) has had several definitions in the last decade, including the Society for Cardiovascular Angiography and Interventions (SCAI) definition, that requires marked biomarker elevations congruent with surgical PMI criteria.
Methods And Results:
The aim of this study was to examine the definition-based frequencies of PMI and whether they influenced the reported association between PMI and increased rates of late death/ myocardial infarction (MI). We studied 742 patients; 492 (66%) had normal troponin T (TnT) levels and 250 (34%) had elevated, but stable or falling, TnT levels. PMI, using the 2007 and the 2012 universal definition, occurred in 172 (23.2%) and in 99 (13.3%) patients, respectively, whereas 19 (2.6%) met the SCAI PMI definition (P<0.0001). Among patients with PMI using the 2012 definition, occlusion of a side branch ≤1 mm occurred in 48 patients (48.5%) and was the most common angiographic finding for PMI. The rates of death/MI at 2 years in patients with, compared to those without, PMI was 14.7% versus 10.1% (P=0.087) based on the 2007 definition, 16.9% versus 10.3% (P=0.059) based on the 2012 definition, and 29.4% versus 10.7% (P=0.015) based on the SCAI definition.
Conclusion:
In this study, PMI, according to the SCAI definition, was associated with more-frequent late death/MI, with ≈20% of all patients, who had PMI using the 2007 universal MI definition, not having SCAI-defined PMI. Categorizing these latter patients as SCAI-defined no PMI did not alter the rate of death/MI among no-PMI patients.
Insights
The Society for Cardiovascular Angiography and Interventions (SCAI) definition of periprocedural myocardial infarction (PMI) identifies patients with higher rates of late death. Using the SCAI definition for PMI is crucial for accurate risk assessment.
Area of Science:
- Cardiology
- Biomarkers
- Clinical Outcomes
Background:
- Periprocedural myocardial infarction (PMI) lacks a universally consistent definition, impacting clinical interpretation.
- Existing definitions, including the Society for Cardiovascular Angiography and Interventions (SCAI) criteria, vary in their diagnostic thresholds.
Purpose of the Study:
- To evaluate the impact of different PMI definitions on event frequencies.
- To determine if varying PMI definitions influence the association between PMI and late death/myocardial infarction (MI).
Main Methods:
- Analysis of 742 patients undergoing cardiac procedures.
- Comparison of PMI incidence using the 2007 universal definition, 2012 universal definition, and the SCAI definition.
- Assessment of 2-year rates of death/MI based on PMI classification.
Main Results:
- PMI incidence varied significantly by definition: 23.2% (2007), 13.3% (2012), and 2.6% (SCAI).
- The SCAI definition identified a subset of patients with significantly higher rates of late death/MI (29.4%) compared to other definitions.
- Side branch occlusion ≤1 mm was the most common angiographic finding in SCAI-defined PMI.
Conclusions:
- The SCAI definition of PMI is associated with increased late death/MI rates.
- A substantial proportion of patients meeting the 2007 universal definition did not meet the SCAI criteria, highlighting definitional discrepancies.
- Adopting the SCAI definition may refine risk stratification for patients experiencing periprocedural myocardial infarction.
Related Concept Videos
Acute Coronary Syndrome IV: Interprofessional Care
Acute Coronary Syndrome I: Introduction
Cardiac Catheterization I: Pre-Procedure Overview
Myocarditis I: Introduction
Myocarditis II: Clinical Features and Diagnostic Tests
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

